John Nuss, CHIEF SCIENTIFIC OFFICER at Ventyx Biosciences, Inc. (VTYX), sold 13,161 shares at $2.26 ($30K) on 2024-12-19, disclosed to the SEC on 2024-12-19.
Open-market sale of $30k VTYX by CHIEF SCIENTIFIC OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| VTYX | SELL | 2024-12-30 | $50K | — | Filing → |
| VTYX | SELL | 2024-04-03 | $9K | — | Filing → |
| VTYX | SELL | 2023-12-21 | $37K | — | Filing → |